Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Melanocyte Adhesion and Apoptosis in Vitiligo: Linking Puzzle Blocks

Author(s): Niharika Srivastava, Sarika Gupta* and Davinder Parsad

Volume 23, Issue 8, 2023

Published on: 03 September, 2022

Page: [709 - 711] Pages: 3

DOI: 10.2174/1566524022666220621125552

Abstract

Vitiligo is the utmost common depigmenting condition consequential from melanocyte loss from the basal layer of the epidermis. Vitiligo disease mostly affects dark-skinned races and makes them more sensitive to UV radiation. It is also linked with some autoimmune diseases and various psychosocial difficulties. Melanocyte loss leads to depigmentation in vitiligo, is a major concern over decades, and even affects an individual’s day-to-day life severely. All the theories, including autoimmune, autocytotoxic, and neural, collectively decipher either prime impact on the melanogenesis inhibition or deficient adhesion inspired melanocytes disappearance. Previously it has been described that melanocyte loss in vitiligo patients is caused by defective adhesion. Melanocyte death by apoptosis mainly occurs due to melanocyte detachment or migration from the basal layer and further followed by transepidermal migration. Various cell surface molecules, i.e., cell adhesion molecules (CAMs) in affiliation with neighbouring cells and extracellular matrix (ECM), encompass a typical cell adhesion process. All these ECM molecules along with transcription factors, help in the survival and maintenance of pigmentary cells/melanocytes. Therefore, in this issue, we have tried to compile the literature available on melanocyte detachment/apoptosis in ECM due to the alteration in adhesion molecules and matrix metalloproteinases (MMPs) driven by known/unknown transcription factors.

Keywords: Vitiligo, melanocytes, ECM, cell adhesion, MMPs, apoptosis.

Next »
[1]
Ezzedine K, Diallo A, Léauté-Labrèze C, et al. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: A prospective observational study of 213 patients. Br J Dermatol 2011; 165(1): 44-9.
[http://dx.doi.org/10.1111/j.1365-2133.2011.10311.x] [PMID: 21410675]
[2]
Gauthier Y, Cario Andre M, Taïeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16(4): 322-32.
[http://dx.doi.org/10.1034/j.1600-0749.2003.00070.x] [PMID: 12859615]
[3]
Arora A, Kumaran M. Pathogenesis of vitiligo: An update. Pigment International 2017; 4(2): 65-77.
[http://dx.doi.org/10.4103/2349-5847.219673]
[4]
Srivastava N, Bishnoi A, Parsad D, Kumaran MS, Vinay K, Gupta S. Dendritic cells sub-sets are associated with inflammatory cytokine production in progressive vitiligo disease. Arch Dermatol Res 2021; 313(9): 759-67.
[http://dx.doi.org/10.1007/s00403-020-02168-w] [PMID: 33403574]
[5]
Kumar R, Parsad D. Melanocytorrhagy and apoptosis in vitiligo: Connecting jigsaw pieces. Indian J Dermatol Venereol Leprol 2012; 78(1): 19-23.
[http://dx.doi.org/10.4103/0378-6323.90942] [PMID: 22199056]
[6]
Kumar R, Parsad D, Kanwar AJ, Kaul D. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol 2011; 165(2): 285-91.
[http://dx.doi.org/10.1111/j.1365-2133.2011.10324.x] [PMID: 21428970]
[7]
Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taïeb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol 2003; 148(1): 95-101.
[http://dx.doi.org/10.1046/j.1365-2133.2003.05024.x] [PMID: 12534601]
[8]
Srivastava N, Bishnoi A, Mehta S, et al. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo. Exp Dermatol 2020; 29(6): 539-47.
[http://dx.doi.org/10.1111/exd.14107] [PMID: 32350934]
[9]
Boukhedouni N, Martins C, Darrigade AS, et al. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo. JCI Insight 2020; 5(11): 133772.
[PMID: 32369451]
[10]
Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev 2021; 41(2): 1138-66.
[http://dx.doi.org/10.1002/med.21754] [PMID: 33200838]
[11]
Reisdorff J, En-Nia A, Stefanidis I, Floege J, Lovett DH, Mertens PR. Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells. J Am Soc Nephrol 2002; 13(6): 1568-78.
[http://dx.doi.org/10.1097/01.ASN.0000015617.39974.FB] [PMID: 12039986]
[12]
Reichert Faria A, Jung JE, Silva de Castro CC, de Noronha L. Reduced immunohistochemical expression of adhesion molecules in vitiligo skin biopsies. Pathol Res Pract 2017; 213(3): 199-204.
[http://dx.doi.org/10.1016/j.prp.2016.12.019] [PMID: 28214208]
[13]
Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem 1999; 274(31): 21491-4.
[http://dx.doi.org/10.1074/jbc.274.31.21491] [PMID: 10419448]
[14]
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003; 92(8): 827-39.
[http://dx.doi.org/10.1161/01.RES.0000070112.80711.3D] [PMID: 12730128]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy